Pathophysiology of Cardiac Performance
Heart Failure Drugs: Inotropic Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 23, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Farman Ali1, Khurram Arshad1, Rabia Latif2
1Department of Cardiology, Corewell Health Dearborn Hospital, Dearborn, MI, USA.
Cardiac contractility modulation (CCM) offers a promising treatment for heart failure with reduced ejection fraction (HFrEF). This article emphasizes the need for provider training and a troubleshooting algorithm to optimize CCM device management for better patient outcomes.
Area of Science:
Background: